<DOC>
	<DOCNO>NCT02975934</DOCNO>
	<brief_summary>The purpose study determine patient metastatic castration-resistant prostate cancer , evidence homologous recombination gene deficiency , respond treatment rucaparib verse treatment physician 's choice abiraterone acetate , enzalutamide , docetaxel .</brief_summary>
	<brief_title>A Study Rucaparib Verses Physician 's Choice Therapy Patients With Metastatic Castration-resistant Prostate Cancer Homologous Recombination Gene Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Rucaparib</mesh_term>
	<mesh_term>Abiraterone Acetate</mesh_term>
	<criteria>Be 18 year old time inform consent sign Have histologically cytologically confirm adenocarcinoma poorly differentiate carcinoma prostate Be surgically medically castrate , serum testosterone level â‰¤ 50 ng/dL ( 1.73 nM ) Be eligible treatment physician 's choice comparator treatment ( abiraterone acetate , enzalutamide docetaxel ) Experienced disease progression receive 1 prior next generation androgen receptortargeted therapy castrationresistant disease Have deleterious mutation BRCA1/2 ATM gene Active second malignancy , exception curatively treat non melanoma skin cancer , carcinoma situ , superficial bladder cancer Prior treatment PARP inhibitor Prior treatment chemotherapy metastatic castrationresistant prostate cancer Symptomatic and/or untreated central nervous system metastases Preexisting duodenal stent and/or gastrointestinal disorder defect would , opinion investigator , interfere absorption study drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>CRPC</keyword>
	<keyword>PARP inhibitor</keyword>
	<keyword>PARPi</keyword>
	<keyword>BRCA</keyword>
	<keyword>ATM</keyword>
	<keyword>HRD</keyword>
	<keyword>TRITON</keyword>
	<keyword>homologous recombination</keyword>
	<keyword>DNA repair</keyword>
	<keyword>DNA defect</keyword>
	<keyword>DNA anomaly</keyword>
	<keyword>germline</keyword>
	<keyword>somatic</keyword>
</DOC>